Mesenchymal stem cells (MSCs), a major compartment of the TME, have been shown to promote HCC progression through YAP1-mediated lipogenesis reprogramming in hypoxic conditions [49]. The gene discussed is YAP1; the disease is hepatocellular carcinoma.